Communiqués Ainos, Inc.

Actions

AIMD

US00902F4028

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
1,340 ^USD	-6,94 %		-9,46 %	-18,29 %

03/08	Ainos, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
27/05	Les plus fortes baisses de l'avant-bourse	MT

Communiqués

24/09	Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework	AQ
16/09	VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset	AQ
14/09	Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing	AQ
09/09	Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era	AQ
19/08	Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management	AQ
17/08	Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence	AQ
13/08	Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances	AQ
12/08	Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026	AQ
10/08	VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset	AQ
06/08	Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications	AQ
03/08	Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets	AQ
21/07	Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI	AQ
22/06	VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence	AQ
17/06	Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program	AQ
08/06	Ainos Releases 2026 Mid-Year CEO Letter to Shareholders	AQ
05/06	VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations	AQ
03/06	Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study	AQ
01/06	Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis	AQ
20/05	VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence	AQ
18/05	Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization	AQ
13/05	Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets	AQ
11/05	Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus	AQ
17/04	VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability	AQ
08/04	Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments	AQ
01/04	VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum	AQ